Elite Pharmaceuticals, Inc. (ELTP)

Elite Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	21.74	11.32	7.11	7.83	8.54	3.19
Cash & Short-Term Investments	21.74	11.32	7.11	7.83	8.54	3.19
Cash Growth	158.56%	59.23%	-9.27%	-8.24%	167.33%	182.11%
Receivables	36.22	29.21	19.45	3.09	3.06	3.5
Inventory	19.36	16.24	12.93	9.55	6.74	5.01
Prepaid Expenses	0.55	0.98	0.52	1.03	0.53	0.49
Total Current Assets	77.86	57.74	40.01	21.51	18.86	12.19
Property, Plant & Equipment	13.81	14.1	14.61	10.44	6.98	6.86
Other Intangible Assets	0.29	0.29	0.29	0.29	0.47	0.47
Long-Term Deferred Tax Assets	13.48	18.37	22.16	2.17	2.17	-
Long-Term Deferred Charges	5.35	5.35	6.05	6.05	6.17	6.17
Other Long-Term Assets	0.55	0.55	0.53	0.43	0.5	0.5
Total Assets	111.34	96.39	83.65	40.9	35.15	26.19
Accounts Payable	5.09	2.96	2.71	2.45	1.43	0.93
Accrued Expenses	3.83	3.45	4.82	4.63	4.28	4.27
Short-Term Debt	-	4	4	-	-	-
Current Portion of Long-Term Debt	0.23	0.25	0.3	0.31	0.35	0.41
Current Portion of Leases	0.86	0.84	0.72	0.01	0.2	0.19
Current Income Taxes Payable	0.75	0.34	0.49	0.41	0.41	-
Current Unearned Revenue	0	0.01	0.01	0.01	0.01	0.01
Total Current Liabilities	10.76	11.84	13.05	7.83	6.69	5.81
Long-Term Debt	3.01	3.03	3.28	3.56	1.39	1.74
Long-Term Leases	2.57	2.8	3.44	-	0.84	0.04
Long-Term Unearned Revenue	-	-	0.01	0.02	0.03	0.05
Other Long-Term Liabilities	47.31	25.2	6.3	0.52	0.98	2.4
Total Liabilities	63.66	42.87	26.07	11.94	9.93	10.04
Common Stock	1.07	1.07	1.07	1.01	1.01	1.01
Additional Paid-In Capital	173.51	173.46	173.21	164.75	164.58	164.41
Retained Earnings	-126.59	-120.7	-116.39	-136.5	-140.06	-148.96
Treasury Stock	-0.31	-0.31	-0.31	-0.31	-0.31	-0.31
Total Common Equity	47.68	53.52	57.58	28.96	25.22	16.15
Shareholders' Equity	47.68	53.52	57.58	28.96	25.22	16.15
Total Liabilities & Equity	111.34	96.39	83.65	40.9	35.15	26.19
Total Debt	6.68	10.91	11.74	3.89	2.78	2.38
Net Cash (Debt)	15.06	0.4	-4.63	3.94	5.75	0.81
Net Cash Growth	-	-	-	-31.44%	606.63%	-
Net Cash Per Share	0.01	0.00	-0.00	0.00	0.01	0.00
Filing Date Shares Outstanding	1,071	1,068	1,068	1,014	1,011	1,009
Total Common Shares Outstanding	1,068	1,068	1,068	1,014	1,011	1,009
Working Capital	67.1	45.9	26.96	13.68	12.17	6.38
Book Value Per Share	0.04	0.05	0.05	0.03	0.02	0.02
Tangible Book Value	47.39	53.23	57.29	28.67	24.76	15.69
Tangible Book Value Per Share	0.04	0.05	0.05	0.03	0.02	0.02
Land	11.65	11.65	11.06	10.77	5.46	5.46
Machinery	15.92	15.71	15.02	14.24	13.85	13.35

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.